Cognitive and biochemical processes in depressed adult outpatients: A test of the circular process model

Journal of Behavior Therapy and Experimental Psychiatry

Volumn 32, Issue 2, 2001, Pages 91-104

  Oei, Tian P S ^a   Dingle, Genevieve ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; NORADRENALIN; VANILMANDELIC ACID;

ADULT; ARTICLE; COGNITION; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; OUTPATIENT; PSYCHOBIOLOGY; QUESTIONNAIRE; REGRESSION ANALYSIS; THINKING;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; CATECHOLAMINES; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; MONOAMINE OXIDASE; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 0034769057     PISSN: 00057916     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-7916(01)00024-6     Document Type: Article

References (42)

1. Overview of recent research in depression
2. Psychotherapy versus medication for depression; Challenging the conventional wisdom with data
3. The mediator-moderator variable distinction in social psychological research; Conceptual, strategic and statistical considerations
4. Cognitive models of depression
5. Self-concept dimensions of clinically depressed and anxious outpatients
6. The assessment of pessimism; The hopelessness scale
7. Changes in urinary catecholamines and their metabolites in depressed patients treated with Amitriptyline or Imipramine
8. High urinary norepinephrine excretion in major depressive disorders; Effects of a new type of MAO inhibitor (Moclobemide, RO 11-1163)
9. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls
10. How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression
11. Cognitive assessment of depression; Reliability and validity of three measures
12. Biological and cognitive processes in the treatment and maintenance of depression
13. Biological and psychological processes in recovery from depression during cognitive therapy
14. Changes in urinary MHPG during treatment of depression with Imipramine
15. Depression versus anxiety; A test of the content-specificity hypothesis
16. Empirical status of the cognitive theory of depression
17. An empirical investigation of the specificity and sensitivity of the automatic thoughts questionnaire and dysfunctional attitudes scale
18. Cognitive self statements in depression; Development of an automatic thoughts questionnaire
19. Cognitive therapy and pharmacotherapy for depression-singly and in combination
20. CSF and urinary biogenic amines and metabolites in depression and mania
21. Biological markers of depression; Who multi-center studies and future perspective
22. The roles of two levels of cognitions in the development, maintenance, and treatment of depression
23. Effect of low-dose clorgyline on 24-h urinary MHPG excretion in patients with rapid cycling bipolar affective disorder
24. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients
25. Electroconvulsive treatment and lithium carbonate; Their effects on norepinephrine metabolism of patients with primary major depressions
26. Dysfunctional attitudes are mood-state dependent
27. Endorsement of dysfunctional beliefs depends on current mood state
28. Do cognitive behaviour therapies validate cognitive models of mood disorders? A review of the empirical evidence
29. The dysfunctional attitudes scale; Psychometric properties and relation to depression in an unselected adult population
30. The catecholamine hypothesis of affective disorders; A review of supporting evidence
31. Catecholamine metabolism in affective disorders; I Normetanephrine and VMA excretion in depressed patients treated with Imipramine
32. Toward an integration of psychologic, social, and biologic factors in depression; Effects on outcome and course of cognitive therapy
33. A self rating depression scale